Multiple sites on Streptococcus gordonii surface protein PadA bind to platelet GPIIbIIIa

Summary

Infective endocarditis is a life threatening disease caused by a bacterial infection of the endocardial surfaces of the heart. The oral pathogen, Streptococcus gordonii is amongst the most common pathogens isolated from infective endocarditis patients. Previously we identified a novel cell wall protein expressed on S. gordonii called platelet adherence protein A (PadA) that specifically interacts with platelet GPIIb/IIIa. The interaction between PadA and GPIIb/IIIa resulted in firm platelet adhesion, dense granule secretion and platelet spreading on immobilised S. gordonii. This study set out to identify specific motifs on the PadA protein that interacts with platelet GPIIb/IIIa. Proteomic analysis of the PadA protein identified two short amino acid motifs which have been previously shown to be important for fibrinogen binding to GPIIb/IIIa and contributing to the generation of outside-in signalling. Site directed mutagenesis on the PadA protein in which ₄₅₄AGD was substituted to AAA, and the ₃₈₃RGT was substituted to AAA suggests the RGT motif has no role in supporting platelet adhesion however plays a role in dense granule secretion and platelet spreading. In contrast to this the AGD motif has no role to play in supporting firm platelet adhesion or dense granule secretion however plays a role in platelet spreading. These results suggest that multiple sites on S. gordonii PadA interact with GPIIb/IIIa to mediate a number of platelet responses that likely contribute to the thrombotic complications of infective endocarditis.

Keywords

Bacterial surface protein - platelet adhesion - aggregation - spreading - dense granule release - shear adhesion

^* These authors contributed equally to work presented in this manuscript.

• References

• 1 Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363: 139-149.
• 2 Durack DT. Prevention of infective endocarditis. N Engl J Med 1995; 332: 38-44.
• 3 Ruggeri ZM. Platelet adhesion under flow. Microcirculation 2009; 16: 58-83.
• 4 Moreillon P. et al. Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin North Am 2002; 16: 297-318.
• 5 Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when?. Circulation 2010; 121: 1141-1152.
• 6 Castillo JC. et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart 2000; 83: 525-530.
• 7 Murdoch DR. et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169: 463-473.
• 8 Jault F. et al. Active native valve endocarditis: determinants of operative death and late mortality. Ann Thorac Surg 1997; 63: 1737-1741.
• 9 Remadi JP. et al. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. Ann Thorac Surg 2007; 83: 1295-1302.
• 10 Thuny F. et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005; 112: 69-75.
• 11 Heiro M. et al. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000; 160: 2781-2787.
• 12 Tleyjeh IM. et al. A systematic review of population-based studies of infective endocarditis. Chest 2007; 132: 1025-1035.
• 13 Nobbs AH. et al. Streptococcus adherence and colonisation. Microbiol Mol Biol Rev 2009; 73: 407-450.
• 14 Douglas CW. et al. Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol 1993; 39: 179-182.
• 15 Petersen HJ. et al. Human platelets recognize a novel surface protein, PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa. Infect Immun 2010; 78: 413-422.
• 16 Cox D. et al. Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov 2010; 9: 804-820.
• 17 Shattil SJ. et al. Adhesive signaling in platelets. Curr Opin Cell Biol 1994; 6: 695-704.
• 18 Clemetson KJ. Platelets and primary haemostasis. Thromb Res 2012; 129: 220-224.
• 19 Kloczewiak M. et al. Localisation of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain. Biochem Biophys Res Commun 1982; 107: 181-187.
• 20 Keane C. et al. Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii. Arte-rioscler Thromb Vasc Biol 2010; 30: 2408-2415.
• 21 Kerrigan SW. et al. Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. Arterioscler Thromb Vasc Biol 2008; 28: 335-340.
• 22 Plummer C. et al. A serine-rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb. Br J Haematol 2005; 129: 101-109.
• 23 Kerrigan SW. et al. Role of Streptococcus gordonii surface proteins SspA/SspB and Hsa in platelet function. Infect Immun 2007; 75: 5740-5747.
• 24 Liu Q. et al. Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads. Biochim Biophys Acta 1998; 1385: 33-42.
• 25 Kerrigan SW, Cox D. Platelet-bacterial interactions. Cell Mol Life Sci 2010; 67: 513-523.
• 26 Plow EF. et al. Ligand binding to integrins. J Biol Chem 2000; 275: 21785-21788.
• 27 Farrell DH, Thiagarajan P. Binding of recombinant fibrinogen mutants to platelets. J Biol Chem 1994; 269: 226-231.
• 28 Bensing BA. et al. The Streptococcus gordonii surface proteins GspB and Hsa mediate binding to sialylated carbohydrate epitopes on the platelet membrane glycoprotein Ibalpha. Infect Immun 2004; 72: 6528-6537.
• 29 Farrell DH. et al. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992; 89: 10729-10732.
• 30 Zaidi TN. et al. Adhesion of platelets to surface-bound fibrinogen under flow. Blood 1996; 88: 2967-2972.
• 31 Savage B. et al. Interaction of integrin alpha IIb beta 3 with multiple fibrinogen domains during platelet adhesion. J Biol Chem 1995; 270: 28812-28817.
• 32 Phillips DR. et al. Integrin tyrosine phosphorylation in platelet signaling. Curr Opin Cell Biol 2001; 13: 546-554.
• 33 Obergfell A. et al. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. J Cell Biol 2002; 157: 265-275.
• 34 Savage B, Ruggeri ZM. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J Biol Chem 1991; 266: 11227-11233.
• 35 Italiano Jr. JE. et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008; 111: 1227-1233.
• 36 Remijn JA. et al. Mutations on fibrinogen (gamma 316-322) are associated with reduction in platelet adhesion under flow conditions. Ann NY Acad Sci 2001; 936: 444-448.
• 37 Podolnikova NP. et al. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa). Biochemistry 2005; 44: 16920-16930.